Orbiva and Articura Sign MOU for Healthcare AI in Indonesia
Orbiva, a wholly owned subsidiary of Home Control International, signed a strategic cooperation MOU with Indonesia based Articura on July 23, 2026, the companies announced in a press release. At the signing ceremony, Orbiva also introduced products tailored for the Articura project.
The companies plan to work on healthcare AI infrastructure and digital health solutions for Indonesia. The scope includes healthcare AI reasoning rule systems, healthcare data and knowledge systems for hospitals and clinics, home healthcare, remote monitoring, digital health records, and AI use in hospital settings.
Planned hospital functions include AI enabled consultation before visits, patient triage, clinical decision support, medical record quality control, patient follow up, and tools for hospital operations. Orbiva will contribute AI, AIoT smart device, healthcare data processing, and edge computing technology, while Articura will provide healthcare deployment experience, hospital system integration, and local hospital networks.
Articura also plans to establish a National AI Healthcare Lab for demonstrations, model validation, research, and professional education. Representatives from Indonesia's Ministry of Health and Ministry of Communication and Digital Affairs attended the signing ceremony.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Sep 20 Litera Brings Foundation Firm AI Search to ChatGPT Enterprise Sep 19 Collinson Funds Priority Pass AI and App Expansion Through £500 Million Program Sep 19 Disney Names Former Character.ai CEO as Its First CTO Sep 19 Anthropic Picks Accenture for AI Safety Testing Sep 19 Huawei Unveils Immersive Telepresence SystemMore from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital
HiRO and Differentia Biotech Sign MOU for AI Clinical Trial Simulation
Atman Health Wins ARPA-H Award to Build Heart Failure AI
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Konko AI Raises $6 Million for Patient Journey Platform
Daily AI Brief: the AI news that matters, in your inbox.